The science
Cellular energy declines when three systems fail: mitochondrial quality control deteriorates, respiratory chain function becomes inefficient, and metabolic flexibility is lost. When these systems break down, they accelerate aging and drive chronic disease. Targeted interventions that clear damaged mitochondria and restore energy production rebuild youthful function and resilience.
How mitochondrial dysfunction impacts healthspan

Interventions can help
Restore energy production
When mitochondria become damaged, they produce less energy while creating harmful waste products that accelerate aging. Methylene blue supports respiratory chain function to enhance cellular power generation and reduce oxidative stress.



Enhance quality control
Rapamycin and urolithin A activate cellular cleanup systems that remove damaged mitochondria and replace them with new, healthy ones, so restoring mitochondrial renewal helps rebuild energy production and reduce inflammation.
Improve metabolic flexibility
SGLT2 inhibitors and physical training in different metabolic zones enhance the ability to switch between different fuel sources, optimizing cellular adaptation to energy demands and improving resilience to support healthy aging throughout life.

Enhance quality control
Rapamycin and urolithin A activate cellular cleanup systems that remove damaged mitochondria and replace them with new, healthy ones, so restoring mitochondrial renewal helps rebuild energy production and reduce inflammation.

Restore energy production
When mitochondria become damaged, they produce less energy while creating harmful waste products that accelerate aging. Methylene blue supports respiratory chain function to enhance cellular power generation and reduce oxidative stress.

Improve metabolic flexibility
SGLT2 inhibitors and physical training in different metabolic zones enhance the ability to switch between different fuel sources, optimizing cellular adaptation to energy demands and improving resilience to support healthy aging throughout life.
Hear from our patients
(Featured In)
(Featured In)
Ahead of the field
“Rapamycin... is at the leading edge of a generation of research trials.”
“I would say that rapamycin is the current best-in-class for a longevity drug”
“Rapamycin... is at the leading edge of a generation of research trials.”
“I would say that rapamycin is the current best-in-class for a longevity drug”
“Rapamycin... is at the leading edge of a generation of research trials.”
“I would say that rapamycin is the current best-in-class for a longevity drug”
“Rapamycin... is at the leading edge of a generation of research trials.”
“I would say that rapamycin is the current best-in-class for a longevity drug”
Reviews
127 reviews
We study the studies
Healthspan longevity experts continuously review the latest clinical research, curating results to help deepen your understanding of aging science.